Jeffrey Yau, PhD, VP of Data Science and Engineering at Walmart Global Technology, Joins BioStar Capital as Entrepreneur in Residence

PETOSKEY, Mich.–()–BioStar Capital, a value-add funding agency targeted on transformational medical gadget applied sciences that serve unmet affected person and doctor wants, at present introduced that Jeffrey Yau, PhD in Economics and VP of Data Science, Data Engineering, and Platform Engineering of Store Associate Tech at Walmart Global Technology, has joined the agency as an entrepreneur in residence (EIR). Dr. Yau was additionally beforehand Chief Data Scientist at AllianceBernstein, a worldwide funding administration and analysis agency with virtually $700B in property underneath administration.

As an EIR, Dr. Yau will develop BioStar’s experience inside the rising area of knowledge science and synthetic intelligence (AI) in healthcare, in addition to determine and consider startups with high-growth potential. Dr. Yau joins BioStar amid an inflection level within the trade as stakeholders throughout the healthcare continuum more and more undertake data-driven applied sciences and AI purposes, a development accelerated by COVID-19. Dr. Yau will leverage his 15+ years of expertise as a results-driven enterprise-wide knowledge science chief, in addition to his ardour for combining rising know-how, machine studying, and superior statistical methods to generate progressive options for difficult enterprise issues.

Dr. Yau joins a novel staff combining the enterprise acumen of seasoned funding professionals, and the scientific experience of world-renowned physicians. The BioStar staff has invested in over 30 medical gadget startups, with practically half acquired by main medical gadget producers, together with Boston Scientific, Medtronic, and Covidien.

“Over the past year and a half, the healthcare industry has experienced an immense amount of change ushering in a new era of technology-driven care with an increasing emphasis on cost efficient value-based models,” mentioned Louis Cannon, MD, Founder and Senior Managing Director, BioStar Capital. “Jeffrey has an extensive track record of success as a data science leader. His depth of experience, academic rigor, as well as his commitment to generating a positive impact on a societal level, will provide immense value to our team, startups, and patients around the world.”

Prior to becoming a member of Walmart, Dr. Yau was the Chief Data Scientist and Global Head of Data Science at AllianceBernstein, the place he was liable for constructing the info science and knowledge engineering groups and main enterprise-wide knowledge science initiatives, reminiscent of creating pure language processing and machine studying algorithms to generate funding indicators, predicting at-risk-of-attrition excessive net-worth retail purchasers, and constructing a knowledge science program to coach inside quantitative analysts and builders. Prior to this function, Dr. Yau was VP and Head of Data Science at Silicon Valley Data Science, the place he led a staff of PhD knowledge scientists serving to Fortune 500 firms sort out enterprise imperatives with knowledge science and A.I. Dr. Yau additionally held a number of different management and knowledge science positions, together with the Head of Quantitative Research and Risk Analytics at Charles Schwab Corporation, Director of Financial Risk Consulting at KPMG, Assistant Director at Moody’s Analytics, and Assistant Professor of Economics at Virginia Tech. He holds a PhD and an MA in Economics with a give attention to Econometrics from the University of Pennsylvania and a BS in Mathematics and Economics from UCLA.

“The healthcare industry has only scratched the surface of what’s possible with data-driven and AI-enabled technologies,” mentioned Dr. Yau. “The BioStar team is well-positioned to get in on the ground floor of this trend, and I’m looking forward to identifying and nurturing startups who are shaping healthcare’s future and, just as importantly, making a meaningful impact on society as a whole.”

About BioStar Capital

BioStar Capital is a strategic value-add funding agency targeted on accelerating worth creation for transformational medical gadget and related well being applied sciences. Combining the perception of skilled funding professionals and world-renowned doctor thought leaders, BioStar identifies proprietary applied sciences that serve unmet affected person and doctor wants and match the acquisition standards of main medical gadget firms. BioStar fills an essential hole in medical gadget innovation and supplies operational expertise and scientific experience along with capital, enabling the agency to actively mitigate danger, optimize product growth, and safe profitable exit. The agency has invested in over 30 med-tech firms, lots of which have been acquired by a significant medical gadget producer. For extra info, go to www.biostar.capital.

LEAVE A REPLY

Please enter your comment!
Please enter your name here